MED12 and Fibroadenoma: Although PTs account for a far lesser proportion of breast fibroepithelial lesions compared to fibroadenomas, both lesions share histomorphological features [20, 21], as well as genetic alterations such as recurrent MED12 mutations [7, 22–24].